Quest Diagnostics, Inc. (DGX)

233.33 +2.24 (+0.97%) USD  |  NYSE  |  Oct 02, 16:00
232.00 -1.33 (-0.57%) After-Hours: 20:00
More

Quest Diagnostics Cash from Operations (TTM) : 1.903B for June 30, 2026

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 1.903B
March 31, 2026 1.85B
December 31, 2025 1.886B
September 30, 2025 1.885B
June 30, 2025 1.678B
March 31, 2025 1.494B
December 31, 2024 1.334B
September 30, 2024 1.397B
June 30, 2024 1.248B
March 31, 2024 1.332B
December 31, 2023 1.272B
September 30, 2023 1.079B
June 30, 2023 1.374B
March 31, 2023 1.332B
December 31, 2022 1.718B
September 30, 2022 1.865B
June 30, 2022 1.924B
March 31, 2022 1.982B
December 31, 2021 2.233B
September 30, 2021 2.293B
June 30, 2021 2.594B
March 31, 2021 2.489B
December 31, 2020 2.005B
September 30, 2020 1.812B
June 30, 2020 1.249B
Date Value
March 31, 2020 1.215B
December 31, 2019 1.243B
September 30, 2019 1.19B
June 30, 2019 1.293B
March 31, 2019 1.295B
December 31, 2018 1.20B
September 30, 2018 1.228B
June 30, 2018 1.188B
March 31, 2018 1.159B
December 31, 2017 1.175B
September 30, 2017 1.156B
June 30, 2017 1.095B
March 31, 2017 1.112B
December 31, 2016 1.069B
September 30, 2016 1.036B
June 30, 2016 947.00M
March 31, 2016 911.00M
December 31, 2015 810.00M
September 30, 2015 842.00M
June 30, 2015 901.00M
March 31, 2015 906.00M
December 31, 2014 938.00M
September 30, 2014 845.35M
June 30, 2014 760.68M
March 31, 2014 688.76M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Labcorp Holdings, Inc. 1.638B
DaVita, Inc. 2.193B
OPKO Health, Inc. -123.38M
Psychemedics Corp. --
NeoGenomics, Inc. 22.05M